{"id":54242,"date":"2023-02-24T23:04:18","date_gmt":"2023-02-24T22:04:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/"},"modified":"2023-02-24T23:04:18","modified_gmt":"2023-02-24T22:04:18","slug":"quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/","title":{"rendered":"Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call"},"content":{"rendered":"
\n

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation<\/a> (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Monday, March 6, 2023, to discuss its fourth quarter earnings and full year 2022 financial results. The call will begin at 8:30 AM Eastern Time. It will be hosted by Masoud Toloue, the Company\u2019s President and Chief Executive Officer, and Michael Doyle, the Company\u2019s Chief Financial Officer.\n<\/p>\n

<\/a><\/p>\n

\nQuanterix will issue a press release regarding the fourth quarter 2022 earnings prior to the conference call. The press release will be posted on the Quanterix website at https:\/\/www.quanterix.com\/<\/a>.\n<\/p>\n

\nClick here<\/a> to pre-register for the conference call and obtain your dial-in number and passcode. You can also visit this link <\/a>to listen to the call via live webcast. You may also access the live webcast by visiting the News & Events<\/a> page within the Investors section of the Quanterix website at www.quanterix.com<\/a>. The webcast will be available on the Company\u2019s website for one year following completion of the call.\n<\/p>\n

\nAbout Quanterix<\/b>\n<\/p>\n

\nFrom discovery to diagnostics, Quanterix\u2019s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company\u2019s Simoa\u00ae <\/sup>technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Limit of Quantification (LoQ) of conventional analog methods. Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 2,000 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https:\/\/www.quanterix.com<\/a> or follow us on Twitter<\/a> and LinkedIn<\/a>.\n<\/p>\n

\nForward-Looking Statements<\/b>\n<\/p>\n

\nThis press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this news release are based on Quanterix\u2019s expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix\u2019s actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Quanterix\u2019s filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:
\n
<\/b>PAN Communications
\n
Maya Nimnicht
\n
510-334-6273
\n
quanterix@pancomm.com<\/a>\n<\/p>\n

\nInvestor Relations:
\n
<\/b>Amy Achorn
\n
(978) 488-1854
\n
ir@quanterix.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Monday, March 6, 2023, to discuss its fourth quarter earnings and full year 2022 financial results. The call will begin at 8:30 AM Eastern Time. It will be hosted by Masoud … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-54242","format-standard","category-industry"],"yoast_head":"\nQuanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Monday, March 6, 2023, to discuss its fourth quarter earnings and full year 2022 financial results. The call will begin at 8:30 AM Eastern Time. It will be hosted by Masoud ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-24T22:04:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230224005379\/en\/778515\/21\/Quanterix_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call\",\"datePublished\":\"2023-02-24T22:04:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/\"},\"wordCount\":494,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005379\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/\",\"name\":\"Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005379\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\",\"datePublished\":\"2023-02-24T22:04:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005379\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005379\\\/en\\\/778515\\\/21\\\/Quanterix_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/","og_locale":"en_US","og_type":"article","og_title":"Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call - Pharma Trend","og_description":"BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Monday, March 6, 2023, to discuss its fourth quarter earnings and full year 2022 financial results. The call will begin at 8:30 AM Eastern Time. It will be hosted by Masoud ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-24T22:04:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230224005379\/en\/778515\/21\/Quanterix_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call","datePublished":"2023-02-24T22:04:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/"},"wordCount":494,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230224005379\/en\/778515\/21\/Quanterix_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/","url":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/","name":"Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230224005379\/en\/778515\/21\/Quanterix_Logo.jpg","datePublished":"2023-02-24T22:04:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230224005379\/en\/778515\/21\/Quanterix_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230224005379\/en\/778515\/21\/Quanterix_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/quanterix-fourth-quarter-earnings-and-full-year-2022-financial-results-conference-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54242"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54242\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}